Nabumetone
Product Images NDC 66267-482

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 66267-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone. The diagram shows the molecular arrangement including a methoxy group and a carboxylic acid group attached to a naphthalene ring system.*

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

This table compares pharmacokinetic parameters for Nabumetone between young adults and elderly subjects at doses of 1,000 mg and 2,000 mg. Parameters include Tmax (hours), half-life (t1/2 in hours), clearance (CLss/F in mL/min), and volume of distribution (Vdss/F in liters), presented as mean ± standard deviation.*

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

This chart shows plasma concentrations of the Nabumetone active metabolite (6MNA) over time at steady state following once-daily dosing of Nabumetone at 1000 mg (n=31) and 2000 mg (n=12). Concentration in mcg/mL is plotted against time in hours, with curves and shaded areas displaying mean levels plus or minus two standard deviations for both doses.*

FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

A data table listing the metabolism breakdown of nabumetone and its various metabolites, including percentages of unchanged nabumetone, 6-methoxy-2-naphthylacetic acid (6MNA), 6MNA conjugated, 6-hydroxy-2-naphthylacetic acid (6HNA) unchanged and conjugated, 4-(6-hydroxy-2-naphthyl)-butan-2-ol conjugated, O-desmethyl-nabumetone conjugated, unidentified minor metabolites, and the total percentage dose.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

This table presents data on the dose of Nabumetone in milligrams, the number of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) at each dose, and the mean and mode duration of treatment in years for both OA and RA patients.*

FDA Label Image

Pdp (66267 482 60 A117)

Nabumetone 500 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates a quantity of 60 tablets, prescription only, with each oval-shaped white tablet debossed with '1G' on one side and '257' on the other. Storage instructions specify controlled temperature of 68-77°F. The label includes NDC 66267-482-60 and a product number P0482060PED.*

FDA Label Image

Structural Formula Of Nabumetone (Image 01)

Chemical structure diagram of the active ingredient Nabumetone, showing its molecular formula C15H16O2 and molecular weight 228.3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.